Table 3 Characteristics of neonates with NAS submitted to pharmacologic treatment
Newborn | 1 | 2 | 3 | 4 |
|---|---|---|---|---|
Birth year | 2010 | 2011 | 2014 | 2017 |
Sex | Male | Female | Female | Female |
Gestational age [weeks] | 38 | 35 | 38 | 38 |
Birthweight [gram] | 2705 | 2675 | 2500 | 2625 |
Milk | Formula | Breast/Formula | Formula | Formula |
Total length of stay [days] | 28 | 13 | 30 | 16 |
NICU admission (main cause) | Yes (social) | Yes (jaundice) | Yes (social) | No (-) |
Length of stay at NICU [days] | 28 | 8 | 30 | - |
ESC approach* | ||||
Poor breastfeeding / <30mL per feed | Yes | Yes | No | Yes |
Sleep < 1 h | Yes | No | No | No |
Difficult to console (> 10 min) | Yes | Yes | Yes | Yes |
Highest FNAS [points] | 20 | 17 | 23 | 19 |
Age at NAS diagnosis [days] | 0 | 3 | 2 | 2 |
Pharmacologic treatment | Methadone | Methadone | Methadone | Methadone |
Duration of pharmacologic treatment [days] | 21 | 2 | 25 | 5 |